Reference no: EM133763612

Question

Parkinson's Disease is a progressive neurodegenerative disorder primarily characterized by motor symptoms. There is a significant proportion of individuals with Parkinson's disease that develop dementia. This involves the cognitive decline affecting memory executive functioning and visuospatial abilities. The prevalence of Parkinson's disease dementia is substantial with estimates suggesting that up to 80% of individuals with Parkinson's disease may develop dementia throughout their illness. Cognitive decline severely impacts the quality of life not only for the patients but also for their families and caregivers. Research indicates that the onset of dementia and Parkinson's patients is associated with increased mortality. A study published by the journal Movement Disorders found that individuals with Parkinson's disease dementia have a higher mortality rate compared to those with regular Parkinson's disease. Cognitive decline accelerates the progression of the disease leading to complications such as falls, infections, and overall decreased physical health. The economic burden of Parkinson's disease dementia is profound. There are cost including medical expenses for hospitalizations, medications, and long-term care facilities increase this cost. According to a study in Alzheimer's and dementia: the Journal of Alzheimer's Association, the annual cost of care with patients with Parkinson's symmetric can be significantly.